Zhuhai Yufan Biotechnologies Co., Ltd

This is the first-ever study in humans of a new oral medication called PRJ1-3024 for people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also look for…